SCHEMBL21967147

SCHEMBL21967147

Fc1ccc(Nc2nc(F)nc3c2ncn3C2CCCCO2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 7/20 0.60
YTHDC1 Q96MU7 1/20 0.53
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP2C19 P33261 1/20 0.44
CDK1 P06493 2/20 0.43
TP53 P04637 1/20 0.41
CYP2C9 P11712 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
APEX1 P27695 1/20 0.41
PI4KA P42356 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
ADCY1 Q08828 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21967846 0.97 FLT3 (0.56) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967400 0.93 FLT3 (0.59) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967706 0.92 FLT3 (0.72) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967801 0.92 FLT3 (0.58) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967824 0.92 FLT3 (0.58) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967315 0.91 FLT3 (0.59) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967445 0.90 FLT3 (0.64) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967831 0.90 FLT3 (0.58) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967784 0.90 FLT3 (0.58) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967861 0.89 FLT3 (0.55) FLT3YTHDC1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662194-B2 Substituted 6-anilino-9-heterocyclylpurine derivatives for inhibition of plant stress UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2020-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662194-B2 Substituted 6-anilino-9-heterocyclylpurine derivatives for inhibition of plant stress TPMT, MTAP, ATIC FLT3 2877/4885YTHDC1 384/4885NPC1 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.